BIOMAT Database Logo BIOMAT Database Logo

[The clinical evaluation of a new antileukemic agent. 2) Neocarzinostatin (author's transl)]. 1974

K Kitajima

UI MeSH Term Description Entries
D007938 Leukemia A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006) Leucocythaemia,Leucocythemia,Leucocythaemias,Leucocythemias,Leukemias
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009353 Zinostatin An enediyne that alkylates DNA and RNA like MITOMYCIN does, so it is cytotoxic. Neocarzinostatin
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000208 Acute Disease Disease having a short and relatively severe course. Acute Diseases,Disease, Acute,Diseases, Acute
D000903 Antibiotics, Antineoplastic Chemical substances, produced by microorganisms, inhibiting or preventing the proliferation of neoplasms. Antineoplastic Antibiotics,Cytotoxic Antibiotics,Antibiotics, Cytotoxic

Related Publications

K Kitajima
[The chemotherapy of acute promyelocytic leukemia with a new antileukemic agent "neocarzinostatin" (author's transl)].
September 1974, [Rinsho ketsueki] The Japanese journal of clinical hematology,
K Kitajima
[Clinical evaluation of new antileukemic agent. 1) Cyclocytidine (author's transl)].
October 1974, Nihon Ketsueki Gakkai zasshi : journal of Japan Haematological Society,
K Kitajima
[Reinduction chemotherapy of acute leukemia with neocarzinostatin and other conventional antileukemic agents (author's transl)].
August 1976, [Rinsho ketsueki] The Japanese journal of clinical hematology,
K Kitajima
[Clinical evaluation of the new antiinflammatory agent (clonoxin) in oral surgery (author's transl)].
January 1974, Nihon Koku Geka Gakkai zasshi,
K Kitajima
[Evaluation of a new antirheumatic agent in general practice (author's transl)].
September 1975, Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis,
K Kitajima
Homoharringtonine as a new antileukemic agent.
May 1985, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
K Kitajima
[Prazosin--a new antihypertensive agent (author's transl)].
June 1976, Deutsche medizinische Wochenschrift (1946),
K Kitajima
[A new intracavitary pacemaker electrode. Clinical evaluation (author's transl)].
January 1981, La Nouvelle presse medicale,
K Kitajima
[Clinical evaluation of new anxiolytic drugs (author's transl)].
May 1982, La Nouvelle presse medicale,
K Kitajima
[Cyclosporin A - a new immunosuppressive agent (author's transl)].
November 1981, Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis,
Copied contents to your clipboard!